Comments on article by Albers et al: "Low-dose fluvoxamine as an adjunct to reduce olanzapine therapeutic dose requirements: a prospective dose-adjusted drug interaction strategy"

J Clin Psychopharmacol. 2005 Dec;25(6):626-7; author reply 627-8. doi: 10.1097/01.jcp.0000186899.34120.af.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antidepressive Agents, Second-Generation / administration & dosage*
  • Antidepressive Agents, Second-Generation / pharmacokinetics
  • Antipsychotic Agents / administration & dosage*
  • Antipsychotic Agents / metabolism
  • Benzodiazepines / administration & dosage
  • Benzodiazepines / metabolism
  • Dose-Response Relationship, Drug
  • Drug Interactions
  • Drug Therapy, Combination
  • Fluvoxamine / administration & dosage*
  • Fluvoxamine / pharmacokinetics
  • Humans
  • Olanzapine
  • Psychotic Disorders / blood
  • Psychotic Disorders / drug therapy

Substances

  • Antidepressive Agents, Second-Generation
  • Antipsychotic Agents
  • Benzodiazepines
  • Olanzapine
  • Fluvoxamine